Aliskiren, a renin inhibitor, downregulates TNF-α-induced tissue factor expression in HUVECS

Angiotensin (Ang)II, the effector arm of the locally active renin—angiotensin system (RAS), modulates Tissue Factor (TF), the principal initiator of blood coagulation and a key promoter of atherothrombotic events. Consistent with that knowledge, previous data showed inhibitory properties of angiotensin-converting enzyme inhibitor (ACEI)s and angiotensin II type-1 receptor blocker (ARB)s, but no data are available about the effect of renin inhibition. We aimed to evaluate whether aliskiren, a direct renin inhibitor (DRI), modulates TNF-α-stimulated TF expression in cultured human umbilical vein endothelial cells (HUVECs). Zofenopril, an ACEI, and olmesartan, an ARB, were the controls. HUVECs were incubated with experimental drugs (1 nM) 30 min prior to TNF-α stimulation (0.1 ng/ml × 4 h). Main evaluation variables were procoagulant activity (single-stage clotting assay), TF antigen (ELISA) and mRNA expression (real-time polymerase chain reaction) in cell lysates. TNF-α stimulated procoagulant activity and increased TF antigen and mRNA expression. Aliskiren inhibited TNF-α-mediated TF stimulation; zofenopril and olmesartan exerted a comparable effect. We conclude that aliskiren, a DRI, downregulates TNF-α-stimulated TF expression in HUVECs, possibly as a reflection of endothelial renin activation by the cytokine.

[1]  K. Nitta,et al.  Dynamic Observation of Mechanically-Injured Mouse Femoral Artery Reveals an Antiinflammatory Effect of Renin Inhibitor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[2]  K. Dellsperger,et al.  Role of TNF-α in vascular dysfunction , 2009, Clinical science.

[3]  C. Sigmund,et al.  Regulation of Renin Gene Expression by Oxidative Stress , 2008, Hypertension.

[4]  R. Pedrinelli,et al.  Tissue factor modulation by Angiotensin II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade? , 2008, Endocrine, metabolic & immune disorders drug targets.

[5]  E. Schiffrin,et al.  Role of the renin-angiotensin system in vascular inflammation. , 2008, Trends in pharmacological sciences.

[6]  W. Yuan,et al.  Intrarenal activation of renin angiotensin system in the development of cyclosporine A induced chronic nephrotoxicity. , 2008, Chinese medical journal.

[7]  R. Pedrinelli,et al.  Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. , 2008, Atherosclerosis.

[8]  X. Li,et al.  Nuclear factor-κB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury , 2008, Current opinion in nephrology and hypertension.

[9]  J. Ingelfinger,et al.  Role of the renin angiotensin system in TNF-α and Shiga-toxin-induced tissue factor expression , 2008, Pediatric Nephrology.

[10]  C. Schnell,et al.  Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets. , 2007, Journal of medicinal chemistry.

[11]  T. Gilmore.  Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.

[12]  Martin Paul,et al.  Physiology of local renin-angiotensin systems. , 2006, Physiological reviews.

[13]  T. Lüscher,et al.  Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications , 2006, Circulation.

[14]  Xiaofan He,et al.  Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes. , 2006, Thrombosis research.

[15]  T. van der Poll,et al.  Bidirectional Relation Between Inflammation and Coagulation , 2004, Circulation.

[16]  P. López-Jaramillo,et al.  Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-α , 2004 .

[17]  P. López-Jaramillo,et al.  Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. , 2004, American journal of physiology. Cell physiology.

[18]  J. Saris,et al.  Prorenin Accumulation and Activation in Human Endothelial Cells: Importance of Mannose 6-Phosphate Receptors , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[19]  K. Nakazato,et al.  Effects of blockade of the renin–angiotensin system on tissue factor and plasminogen activator inhibitor-1 synthesis in human cultured monocytes , 2001, Journal of hypertension.

[20]  D. Ganten,et al.  Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy. , 2000, The American journal of pathology.

[21]  G. Wallukat,et al.  AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. , 2000, Circulation.

[22]  and Roberto Monocytes Angiotensin-Converting Enzyme Inhibitors Downregulate Tissue Factor Synthesis in , 2000 .

[23]  B. Greenberg,et al.  Tumor Necrosis Factor- (cid:97) Upregulates Angiotensin II Type 1 Receptors on Cardiac Fibroblasts , 1999 .

[24]  Y. Jung,et al.  Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist. , 1999, Journal of cardiovascular pharmacology.

[25]  J. Fallon,et al.  Cooperation between VEGF and TNF-alpha is necessary for exposure of active tissue factor on the surface of human endothelial cells. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[26]  K. Nakagawa,et al.  Angiotensin II Increases Plasminogen Activator Inhibitor-1 and Tissue Factor mRNA Expression without Changing that of Tissue Type Plasminogen Activator or Tissue Factor Pathway Inhibitor in Cultured Rat Aortic Endothelial Cells , 1997, Thrombosis and Haemostasis.

[27]  A. Brasier,et al.  Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. , 1996, Hypertension.

[28]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[29]  N. Mackman,et al.  Transcriptional regulation of tissue factor expression in human endothelial cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[30]  G. Pellegrini,et al.  P-selectin induces the expression of tissue factor on monocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  J. Laragh,et al.  Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. , 1994, Circulation.

[32]  A. Guha,et al.  Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. , 1993, The Journal of clinical investigation.

[33]  T. Waldron,et al.  Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting Enzyme , 1989, Journal of cardiovascular pharmacology.

[34]  W. Fiers,et al.  Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[36]  L. Skeggs,et al.  THE PREPARATION, PURIFICATION, AND AMINO ACID SEQUENCE OF A POLYPEPTIDE RENIN SUBSTRATE , 1957, The Journal of experimental medicine.